Breaking News

SGS Adds Stability Testing Services in UK

March 11, 2013

Expands analytical testing for biologics

SGS Life Science Services is developing integrated formulation and stability testing services in the UK, expanding its current capability for characterization-based analytical testing for biologics. The new services will be offered from a dedicated suite in its M-Scan facility in Wokingham, UK and is scheduled to be fully operational by 4Q13.
The 1,100 sq.-ft. suite will include a temperature and access controlled room for the stability units and a large separate instrumentation and wet lab. These new services extend SGS’s formulation and stability services currently provided in Lincolnshire, IL, and stability testing services from its Center of Excellence in Berlin, Germany.
“Customers require preparation and testing of their samples at one site. Sample shipment involved in multisite testing is not ideal because of the potential effects that shipping may have on sample integrity,” said Andrew Reason, group manager, SGS M-Scan Europe. “These studies are also an iterative process whereby data is fed back to the formulation scientists prior to generation of further samples for testing.”
Anne Hays, executive vice president, SGS Life Science Services, said, “There is an increasing trend for biologics manufacturers to outsource testing of their products and SGS strives to provide new services in response to the market’s needs in a timely manner.”
blog comments powered by Disqus
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.